- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Schizophrenia
- Meeting Date: July 2026
Clozapine – July 2026
- Tablet 12.5mg (orally disintegrating)
- Tablet 25mg (orally disintegrating)
- Tablet 50mg (orally disintegrating)
- Tablet 100mg (orally disintegrating)
- Tablet 200mg (orally disintegrating)
Public Summary Documents
Last updated
13 November 2026
